Is visceral adiposity the "enemy within"?

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 6, 2001, Pages 881-883

  Tracy, Russell P ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Cardiovascular disease; Inflammation

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

BODY FAT; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; EDITORIAL; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; VISCERA;

EID: 0035718783     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.6.881     Document Type: Editorial

References (41)

1. Atherosclerosis: An inflammatory disease
2. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies
3. Novel risk factors and markers for coronary disease
4. Inflammation markers and coronary heart disease
5. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening
6. Inflammation in cardiovascular disease: Cart, horse, or both?
7. Fibrinogen and cardiovascular risk
8. Fibrinogen as a risk factor for coronary heart disease
9. C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
10. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects
11. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)
12. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
13. Elevated C-reactive protein: Another component of the atherothrombotic profile of abdominal obesity
14. Abnormalities of coagulation and fibrinolysis in insulin resistance: Evidence for a common antecedent?
15. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo
16. The adipocyte and hemostatic balance in obesity: Studies of PAI-1
17. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin
18. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
19. Inflammation and coagulation: Linked processes potentially regulated through a common pathway mediated by protein C
20. The post-operative fibrinolytic shutdown: A rapidly reverting acute phase pattern for the fast acting inhibitor of tissue-type plasminogen activator after trauma
21. An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: Evidence for differential regulation of insulin signaling by TNF-alpha
22. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): A cohort study
23. The perils of portliness: Causes and consequences of visceral adiposity
24. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women
25. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
26. Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease
27. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
28. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators
29. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women
30. Interleukin-6 exacerbates early atherosclerosis in mice
31. Direct proinflammatory effect of C-reactive protein on human endothelial cells
32. Effect of statins on C-reactive protein in patients with coronary artery disease
33. Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia
34. Association between physical activity and markers of inflammation in a healthy elderly population
35. Hormone replacement therapy, inflammation, and hemostasis in elderly women
36. Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study
37. Hormone replacement therapy and increased plasma concentration of C-reactive protein
38. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: A randomized, controlled trial
39. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women